ViiV Healthcare Announces Data Demonstrating Dovato (DTG/3TC) Is Highly Effective in Treatment-Naïve People With Advanced HIV ...

Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...

CAMBRIDGE, England, Nov. 11, 2024 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat ... response to virus ...

Virologic profiles were assessed among the cohort and classified into 4 categories by HIV RNA levels, including fully suppressed viremia (<20 copies/mL); viral blip or intermittent low-range (20-199 ...

The global synthetic biology market is anticipated to reach USD 31.52 billion in 2029 from USD 12.33 billion in 2024, with a ...

Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Good afternoon, everyone, and welcome to the Atea Pharmaceuticals Third Quarter 2024 Financial Results and Business Update Conference Call.

The Design, Automation, Manufacturing, and Processes Lab and eLabNext announced a formal partnership today to coincide with the kick-off ...

The inaugural Dr. John Karickhoff Medical Innovation Award for Best Overall Research Day Presentation was given to ...

Investigation of the Clade la strain of the virus circulation in Central Africa shows genetic mutations indicative of ...

Genes contain instructions for making proteins, and a central dogma of biology is that this information flows from DNA to RNA to proteins. But only two percent of the human genome actually encodes ...